Roche Diagnostics sales beat market average:
This article was originally published in Clinica
Roche Diagnostics saw its sales rise 14% to SwF5.3 billion ($3.5 billion) in 1999, substantially faster than the global average, the Swiss company says. All four business units contributed to the strong sales. Operating profit rose 29% to SwF771 million. The company is bringing together some diagnostic and therapeutic products to provide integrated healthcare solutions, with packages available for conditions such as HIV, breast cancer and influenza.